Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program
Charlotte Quintens(KU Leuven), Isabel Spriet(KU Leuven), Willy Peetermans(KU Leuven), Paul De Munter(KU Leuven), Katrien Lagrou(KU Leuven), Ester Steffens(KU Leuven), Inge Derdelinckx(Centre Hospitalier Universitaire de Reims), Annette Schuermans(KU Leuven), Johan Van Eldere(Centre for European Policy Studies)
Cited by 60
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
|Thorax|2013|861
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752